Sign in

CIK 0001398733

  • Non-accelerated filer
  • Smaller reporting company

Aquestive Therapeutics, Inc.

Sign in to watch
Ticker
AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208623253
Phone
+1 908-941-1900
Business address
184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
Former names
MonoSol Rx, Inc.
Open-market buys, last 90 days
$99,331
in 1 filing
Open-market sales, last 90 days
$297,289
in 4 filings, $297K under 10b5-1 plans

Net −$197,958. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-12 Davis Matthew W. Chief Development Officer Sale 10b5-1 −7,197 $3.55 $26K 87,500
2026-11-10 Davis Matthew W. Chief Development Officer Shares withheld for taxes −5,303 $3.52 $19K 94,697
2026-03-09 Davis Matthew W. Chief Development Officer Grant or award +50,000 100,000
2026-03-09 Davis Matthew W. Chief Development Officer Grant or award · Non-Qualified Stock Option (right to buy) +50,000 50,000
2025-11-10 Davis Matthew W. Chief Development Officer Grant or award +50,000 50,000
2025-11-10 Davis Matthew W. Chief Development Officer Grant or award · Non-Qualified Stock Option (right to buy) +50,000 50,000

Page 1 of 1 · 6 trades